The present invention relates to sulphonamide compounds for their use in medicine and in the treatment of diseases in a subject such as inflammatory disease, an autoimmune disorder, a cardiovascular disease, a neurodegenerative disease, a disease occurring with uncontrolled cell proliferation and/or differentiation, an angiogenesis-related disease, an allergy, anaphylaxis and alopecia.